# BEONE MEDICINES LTD. (ONC) FY2026 Q1 Balance Sheet

- Company: BEONE MEDICINES LTD. (ONC)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-06, accession number 0001628280-26-030867
- Page: https://plicit.ai/financials/onc/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/onc-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 8,553,619,000 US dollars
- **Current assets**: 6,601,280,000 US dollars
- **Non-current assets**: 1,952,339,000 US dollars
- **Liabilities**: 3,793,177,000 US dollars
- **Current liabilities**: 1,811,510,000 US dollars
- **Non-current liabilities**: 1,981,667,000 US dollars
- **Equity**: 4,760,442,000 US dollars
- **Cash and cash equivalents**: 4,791,676,000 US dollars
- **Accounts receivable, net**: 938,019,000 US dollars
- **Inventories, net**: 681,590,000 US dollars
- **Prepaid expenses and other current assets**: 189,995,000 US dollars
- **Property, plant and equipment, net**: 1,640,918,000 US dollars
- **Operating lease right-of-use assets**: 145,497,000 US dollars
- **Other non-current assets**: 104,243,000 US dollars
- **Intangible assets, net**: 61,681,000 US dollars
- **Accrued expenses and other payables**: 1,079,283,000 US dollars
- **Accounts payable**: 423,546,000 US dollars
- **Short-term debt**: 116,140,000 US dollars
- **Sale of future royalty liability, current portion**: 72,735,000 US dollars
- **Tax payable**: 63,522,000 US dollars
- **Research and development cost share liability, current portion**: 35,700,000 US dollars
- **Operating lease liabilities, current portion**: 20,584,000 US dollars
- **Long-term debt**: 962,515,000 US dollars
- **Sale of future royalty liability, non-current portion**: 831,664,000 US dollars
- **Other long-term liabilities**: 81,952,000 US dollars
- **Deferred tax liabilities**: 55,866,000 US dollars
- **Operating lease liabilities, non-current portion**: 49,670,000 US dollars
- **Additional paid-in capital**: 12,906,326,000 US dollars
- **Ordinary shares, $0.0001 par value per share; 1,540,975,898 and 1,540,975,898 shares issued and 1,444,479,378 and 1,441,075,618 shares outstanding as of March 31, 2026 and December 31, 2025, respectively**: 144,000 US dollars
- **Accumulated deficit**: negative 8,092,546,000 US dollars
- **Accumulated other comprehensive loss**: negative 53,482,000 US dollars
- **Gross equity (calculated)**: 12,906,470,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.